SKY Skyline Corp. (delisted)

* The calculation is based upon 56,713,294 shares of Common Stock being outstanding upon completion of the offering described herein, as disclosed by the Issuer in its prospectus supplement filed with the SEC on March 1, 2019 pursuant to Rule 424(b)(4).

* The calculation is based upon 56,713,294 shares of Common Stock being outstanding upon completion of the offering described herein, as disclosed by the Issuer in its prospectus supplement filed with the SEC on March 1, 2019 pursuant to Rule 424(b)(4).

* The calculation is based upon 56,713,294 shares of Common Stock being outstanding upon completion of the offering described herein, as disclosed by the Issuer in its prospectus supplement filed with the SEC on March 1, 2019 pursuant to Rule 424(b)(4).

* The calculation is based upon 56,713,294 shares of Common Stock being outstanding upon completion of the offering described herein, as disclosed by the Issuer in its prospectus supplement filed with the SEC on March 1, 2019 pursuant to Rule 424(b)(4).

* The calculation is based upon 56,713,294 shares of Common Stock being outstanding upon completion of the offering described herein, as disclosed by the Issuer in its prospectus supplement filed with the SEC on March 1, 2019 pursuant to Rule 424(b)(4).

SCHEDULE 13D

This Amendment No. 6 to the statement on Schedule 13D (“ Amendment No. 6 ”) amends the Schedule 13D originally filed by the Reporting Persons on June 11, 2018, as amended on August 7, 2018, as further amended on August 14, 2018, as further amended on September 25, 2018, as further amended on November 30, 2018 and as further amended on December 7, 2018 (collectively, the “ Schedule 13D ”), relates to the shares of common stock, par value $0.0277 per share (“ Common Stock ”), of Skyline Champion Corporation (the “ Issuer ”). The principal executive offices of the Issuer are located at P.O. Box 743, 2520 By-Pass Road, Elkhart, IN 46515.

Except as specifically provided herein, this Amendment No. 6 does not modify any of the information previously reported on the Schedule 13D.  Capitalized terms used but not otherwise defined in this Amendment No. 6 shall have the meanings ascribed to them in the Schedule 13D.

Item 4. Purpose of Transaction .

Item 4 of the Schedule 13D is hereby amended and supplemented as follows:

Underwriting Agreement

After the close of business on February 27, 2019, the MAK Fund and MAK-ro Fund and certain other Sponsors and other selling shareholders (collectively, the “ Selling Shareholders ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Issuer and Barclays Capital, Inc. (the “ Underwriter ”), pursuant to which the Underwriter agreed to purchase an aggregate of 10,750,202 shares of Common Stock from the Selling Shareholders at the public offering price of $20.46 per share, less the underwriting discount of $0.248 per share. The transaction closed on March 5, 2019. MAK Fund and MAK-ro Fund sold 1,095,000 and 405,000 shares of Common Stock, respectively.

Lock-up Agreement

In connection with the Underwriting Agreement, each of the Selling Shareholders entered into a lock-up agreement (the “ Lock-up Agreement ”) with the Representative. Under the Lock-up Agreement, each Selling Shareholder agreed, subject to specified exceptions, not to offer, sell, pledge or otherwise transfer any shares of Common Stock, or securities convertible into or exercisable or exchangeable for shares Common Stock, for 45 days after February 27, 2019 without first obtaining the written consent of the Representative.

The summaries of the Underwriting Agreement and Lock-up Agreement contained in this Item 4 are qualified in their entirety by reference to the Underwriting Agreement and the Lock-up Agreement, each of which is filed as an exhibit hereto and incorporated by reference herein.

Item 5. Interest in Securities of the Issuer .

Item 5 of the Schedule 13D is hereby amended and supplemented as follows:

(a) – (b) The information contained in rows 7, 8, 9, 10, 11 and 13 on each of the cover pages of this Amendment No. 6 is incorporated by reference in its entirety into this Item 5.

Pursuant to Rule 13d-3 under the Act, the Reporting Persons may be deemed to beneficially own Common Stock as follows: (i) MAK Capital and Mr. Kaufman possess the voting power and dispositive power in respect of 4,039,759 shares; (ii) MAK Champion and MAK Fund possess the voting power and dispositive power in respect of 2,949,024 shares; and (iii) MAK-ro Fund possesses the voting power and dispositive power in respect of 1,090,735 shares.

By virtue of the Investor Rights Agreement and the Coordination Agreement (each of which terminated by their terms upon the completion of the Transaction described in Item 4 of this Amendment No 6), the Reporting Persons and other Sponsors may be deemed to have been members of a “group” (within the meaning of Rule 13d-5 under the Act). However, in connection with the Transaction described in Item 4 of this Amendment No. 6, each of the other Sponsors no longer beneficially own any shares of the Issuer’s outstanding Common Stock and disclaim “group” status within the meaning of Rule 13d-5. The filing of this Amendment No. 6 to the Schedule 13D shall not be deemed an admission that the Reporting Persons and the other Sponsors are or were members of any such group. Each of the other Sponsors has separately filed a Schedule 13D reporting its beneficial ownership of the shares of Common Stock held by it. Each Reporting Person disclaims beneficial ownership of the shares of Common Stock held by each of the other Sponsors.

The calculation is based upon 56,713,294 shares of Common Stock being outstanding upon completion of the offering pursuant to the Underwriting Agreement, as disclosed by the Issuer in its prospectus supplement filed with the SEC on March 1, 2019 pursuant to Rule 424(b)(4).

(c) Except for the sales described in Item 4 above and in the Schedule 13D, no Reporting Person has effected any transactions in the shares of Common Stock during the last 60 days.

Item. 6. Contracts, Arrangements, Understandings or Relationships with respect to Securities of Issuer.

Item 6 of this Schedule 13D is hereby amended and supplemented as follows

The information set forth in Item 4 of this Amendment No. 6 is incorporated by reference in its entirety into this Item 6.

Item 7. Material to be Filed as Exhibits

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.